HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

VEEV

Veeva Systems Inc. (NYSE)

Healthcare — Health Information Services

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Buy 1.9 / 5 27 analysts
$184.55
$-4.69 (-2.48%)
Target: $244.59 (32.5%)
Sign in to add VEEV to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$30.66B
P/E Ratio (TTM)33.47
Forward P/E18.81
EPS (TTM)$5.64
Dividend Yield-
Profit Margin28.37%
Revenue Growth16.30%
ROE13.93%
Debt/Equity1.41
Recommendation Buy 1.9
Analyst Target$244.59
Analysts27
Indexes NYSE

Technical Indicators

RSI (14)73.4
Beta0.95
SMA 20-
SMA 40-
52-Week High$310.50
52-Week Low$148.05
50-Day Avg$164.99
200-Day Avg$213.78
Avg Volume$3.12M
Volume$1.22M

Performance Analysis

BULLISH

VEEV shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 22% of its 52-week range.
- RSI at 73.4 indicates overbought conditions — a pullback may be due.
~ Modest revenue growth of 16.3% year-over-year.
+ Healthy profit margin of 28.4%.
+ Wall Street consensus is "Buy" from 27 analysts.
+ Average analyst target of $244.59 implies 32.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:36 UTC

Back to Screener Export Report